Saturday, October 15, 2022 from 1:45 PM to 3:15 PM PDT at Continental Ballroom 4
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-152-L01-P
Activity Type: A Knowledge-Based Activity
The science and practice of pharmacogenomics is rapidly evolving. This session will provide a future facing outlook of what the practice of pharmacogenomics will hold for pharmacy practitioners, delivering 3 talks focused on the 2-, 5-, and 10-year time horizon. Some areas that the field will soon grapple with include how to implement gene-drug pairs for which there are no guidelines and how the increasing utilization of clinical sequencing technologies will allow us to diagnose genetic diseases and at the same time evaluate pharmacogenetic results to prescribe appropriate medications. In the future, we anticipate that artificial intelligence and machine learning algorithms will be deployed across the electronic health record to identify and refer patients for genetic/pharmacogenetic testing. Pharmacists will need to be prepared for the ever-evolving landscape in the field of pharmacogenomics and precision medicine.
 | Moderator: Sony Tuteja, Pharm.D.
Research Assistant Professor
University of Pennsylvania Perelman School of Medicine
View Biography |
Learning Objectives
1. Identify resources that may be utilized to guide implementation of drug-gene pairs without CPIC guidelines.
2. Discuss genes with implications for disease risk and medications.
3. Explain how genes influencing both disease risk and medications may be implemented in clinical systems.
4. Describe how artificial intelligence will be applied to identify patients at risk for a drug-gene interaction.
5. Discuss challenges in the implementation of novel genes.